Publication | Closed Access

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

Rheumatoid DisorderRheumatologyDouble-blind Phase 3Rheumatic DiseasesPharmacologyClinical TrialsOsteoarthritisInflammatory Rheumatic DiseasePharmacotherapyActive Rheumatoid ArthritisMedicineRheumatoid ArthritisInadequate Response